Form 4: Molina Healthcare Director Receives Equity Award
Director Equity Grant
Molina Healthcare, Inc. reports a director, Steven J. Orlando, received an equity award valued at $55,000 on April 1, 2026, as part of his annual compensation.
Summary
- Steven J. Orlando, a Director at Molina Healthcare, Inc., was granted 405 shares of common stock on April 1, 2026.
- This grant is part of the Issuer's 2025 Equity Incentive Plan and is in recognition of his services as a Director.
- The annual equity award for directors is set at $220,000, with one quarter ($55,000) granted on the first day of each quarter.
- The number of shares granted is based on the closing price of the Issuer's common stock on the grant date, which was $135.82 on April 1, 2026.
- Following the transaction, Mr. Orlando beneficially owns 17,730 shares of common stock, with 1,500 shares held in his 401(k) and the remainder held by the Orlando Family Trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, reporting a standard director equity grant that is part of the company's ongoing compensation practices.
Positives
- Director compensation structure includes equity awards, aligning director interests with shareholders.
- Consistent quarterly equity grants demonstrate a structured approach to director compensation.
- The grant value of $55,000 for the quarter is based on a market price of $135.82, indicating a standard award process.
Future Outlook
The filing indicates a recurring quarterly grant of equity awards to directors, suggesting a consistent approach to compensation and alignment with the company's stock performance.
Industry Context
StockSavvy.ai notes that equity awards for directors are a common practice in the healthcare industry to attract and retain experienced leadership and align their interests with long-term shareholder value. The structure of these awards, tied to stock price and granted quarterly, is typical for publicly traded companies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Steven J. Orlando has executed a Limited Power of Attorney appointing Jeff D. Barlow and Codruta Catanescu to execute Forms 3, 4, and 5 on his behalf. | 02/16/2011 | Ensures timely and accurate filing of beneficial ownership changes as required by Section 16(a) of the Securities Exchange Act of 1934. |
Stakeholder Impact
- Shareholders: The equity grant aligns director compensation with the company's stock performance, potentially incentivizing long-term value creation.
- Employees: The filing does not directly impact employees, but the compensation structure for directors is part of the overall corporate governance framework.
Key Dates
| Date | Description |
|---|---|
| 02/16/2011 | Date of execution for the Limited Power of Attorney for Section 16(a) Filings. |
| 11/08/2005 | Date of revocation of a previous Limited Power of Attorney granted to Jeff D. Barlow and Mark L. Andrews. |
| 04/01/2026 | Transaction date for the grant of common stock to Steven J. Orlando. |
| 04/02/2026 | Date of signature for the Form 4 filing. |
Keywords
Molina Healthcare, MOH, Form 4, Director Compensation, Equity Award, Stock Grant, Beneficial Ownership, Steven J. Orlando, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.